Cargando…
Dose Effects of Recombinant Adenovirus Immunization in Rodents
Recombinant adenovirus type 5 (rAd) has been used as a vaccine platform against many infectious diseases and has been shown to be an effective vaccine vector. The dose of the vaccine varies significantly from study to study, making it very difficult to compare immune responses and vaccine efficacy....
Autor principal: | Weaver, Eric A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963634/ https://www.ncbi.nlm.nih.gov/pubmed/31658786 http://dx.doi.org/10.3390/vaccines7040144 |
Ejemplares similares
-
Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy
por: Watanabe, Maki, et al.
Publicado: (2021) -
Complement activation by recombinant adenoviruses
por: Cichon, G, et al.
Publicado: (2002) -
T Cell-Biased Immune Responses Generated by a Mucosally-targeted Adenovirus-Sigma 1 Vaccine
por: Weaver, Eric A., et al.
Publicado: (2012) -
Analysis of adenovirus DNA detected in rodent species from the Democratic Republic of the Congo indicates potentially novel adenovirus types
por: Kumakamba, C., et al.
Publicado: (2019) -
Perfluorochemical (PFC) liquid enhances recombinant adenovirus vector-mediated viral interleukin-10 (AdvIL-10) expression in rodent lung
por: Li, John T, et al.
Publicado: (2007)